Product Description
CD4 is expressed in a T-cell subset (helper/inducer) and is found in approximately 80% of thymocytes and in 45% of peripheral blood lymphocytes. CD4 is expressed in the majority of T-cell lymphomas including mycosis fungoides, a common form of cutaneous T-cell lymphoma (1).
CD8 has been shown to be an important marker in the analysis of T-cell mediated inflammatory dermatoses and is also useful for analysis of mycosis fungoides (2-4).
CD8 can be used in panels with CD4, CD56, TIA-1 to aid in identifying subsets of inflammatory skin diseases (4). CD4 and CD8 have also been shown to be valuable in squamous cell cervical cancer and gastric mucosa in HIV infection (5-7). The combination of CD4(+) and CD8(-) is helpful in distinguishing mycosis fungoides and can be used in a panel of CD2(+), CD3(+) and CD7(-/+) (1-3). Multiplex IHC may also give distinct advantages if ratios and/or cell counts on a single slide are desired.